These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34817689)

  • 21. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L; Xiang B; Muthuswamy SK
    Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insight into the recognition patterns of the ErbB receptor family transmembrane domains: heterodimerization models through molecular dynamics search.
    Samna Soumana O; Garnier N; Genest M
    Eur Biophys J; 2008 Jul; 37(6):851-64. PubMed ID: 18365190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.
    Mineev KS; Bocharov EV; Pustovalova YE; Bocharova OV; Chupin VV; Arseniev AS
    J Mol Biol; 2010 Jul; 400(2):231-43. PubMed ID: 20471394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.
    Zhang Q; Park E; Kani K; Landgraf R
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13237-42. PubMed ID: 22733765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family.
    Arkhipov A; Shan Y; Kim ET; Dror RO; Shaw DE
    Elife; 2013 Jul; 2():e00708. PubMed ID: 23878723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.
    Fitzpatrick VD; Pisacane PI; Vandlen RL; Sliwkowski MX
    FEBS Lett; 1998 Jul; 431(1):102-6. PubMed ID: 9684874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Molecules and Natural Peptides: Blocking EGFR Cell Signaling Pathways in Cancer: A Mini-Review.
    Patnaik SK; Chandrasekar MJN; Nagarjuna P; Ramamurthi D; Swaroop AK
    Mini Rev Med Chem; 2022 Oct; 22(22):2831-2846. PubMed ID: 35549881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.
    Kennedy SP; Han JZR; Portman N; Nobis M; Hastings JF; Murphy KJ; Latham SL; Cadell AL; Miladinovic D; Marriott GR; O'Donnell YEI; Shearer RF; Williams JT; Munoz AG; Cox TR; Watkins DN; Saunders DN; Timpson P; Lim E; Kolch W; Croucher DR
    Breast Cancer Res; 2019 Mar; 21(1):43. PubMed ID: 30898150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.
    Ward MD; Leahy DJ
    J Biol Chem; 2015 Jan; 290(3):1570-9. PubMed ID: 25468910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disabling receptor ensembles with rationally designed interface peptidomimetics.
    Berezov A; Chen J; Liu Q; Zhang HT; Greene MI; Murali R
    J Biol Chem; 2002 Aug; 277(31):28330-9. PubMed ID: 12011054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
    Johannessen LE; Haugen KE; østvold AC; Stang E; Madshus IH
    Biochem J; 2001 May; 356(Pt 1):87-96. PubMed ID: 11336639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.
    Taylor ES; Pol-Fachin L; Lins RD; Lower SK
    Proteins; 2017 Apr; 85(4):561-570. PubMed ID: 28019699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor.
    Alvarado D; Klein DE; Lemmon MA
    Nature; 2009 Sep; 461(7261):287-91. PubMed ID: 19718021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization.
    Gerber D; Sal-Man N; Shai Y
    J Biol Chem; 2004 May; 279(20):21177-82. PubMed ID: 14985340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization.
    Hughes JB; Berger C; Rødland MS; Hasmann M; Stang E; Madshus IH
    Mol Cancer Ther; 2009 Jul; 8(7):1885-92. PubMed ID: 19584234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
    Monsey J; Shen W; Schlesinger P; Bose R
    J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2.
    Mizutani K; Kedashiro S; Maruoka M; Ueda Y; Takai Y
    Sci Rep; 2017 Sep; 7(1):11375. PubMed ID: 28900130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction.
    Huang GC; Ouyang X; Epstein RJ
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):113-9. PubMed ID: 9512468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.